Search
ADC Therapeutics SA
ADCTAdd to Watchlist
1.070USD
-0.040-3.60%
Close 09-11 16:00（ET）
135.08MMarket Cap
LossP/E TTM
After-hours 19:00 (ET)1.070USD+0.005+0.47%
After-hours 19:00 (ET)ADC Therapeutics SA (ADCT) Revenue Performance
Updated: Jun 30, 2026For the latest quarter, ADC Therapeutics SA reported the revenue of 18.63M USD for the period ending 2026-06-30, which came from the top-performing segment, Product. United States contributed the highest revenue, at 18.63M USD.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
Product
License revenue
Royalties
FY2025
Product
73.55M(90.41%)
License revenue
5.00M(6.15%)
Royalties
2.81M(3.45%)